INVO: INVO Bioscience Expected earnings per share growth for next year
Amidst fierce competition with major IVF networks, INVO Bioscience, Inc. (INVO) is implementing alternative ART methods. Scaling through affordable embryo incubation systems expands target market reach, while the launch of proprietary centers and patent protection generate a stable cash flow. Expected EPS dynamics for the next period reflect market sentiment, with the latest parameter standing at 11.80.
Analytical breakdowns for INVO Bioscience (INVO)
- share price and consensus valuation forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Capital INVO Bioscience, Inc.|INVO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital INVO Bioscience Inc.|INVO - Company Total Debt Obligations|Debts to Book Capitalization INVO Bioscience|INVO - Company Long-Term Liabilities|Company Short-Term Debts INVO Bioscience|Quick Liquidity invobioscience.com
- net income and valuation ratios data:
INVO - Company Net Income|Future Profit INVO Bioscience, Inc.|INVO - Company Value to Net Income|Forward P/E Multiple INVO Bioscience Inc.|INVO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Bioscience|INVO - Operating profit before depreciation charges|Net earnings per share for the last 12 months INVO Bioscience|INVO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth invobioscience.com|INVO - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year INVO Bioscience, Inc.
Initial company analysis:INVO Bioscience, Inc., INVO
This indicator reflects the analysts' consensus forecast for earnings per share growth rates, aggregating complex financial models into a single trend of expected growth. When analyzing the current vector of EPS forecasts for the coming year, investors must consider the moderate cyclicality of IVF services, as the high cost of procedures makes INVO Bioscience, Inc. (INVO) revenue sensitive to consumer demand during periods of economic instability.
Analysis of competing companies
BSX (Boston Scientific Inc) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year EW (Edwards Lifesciences Inc.)|Expected earnings per share growth for next year RMD (ResMed Inc.)|PODD (insulet.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zimmer Biomet Holdings Inc ZBH|COO - Expected earnings per share growth for next year|Align Technology Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year NuVasive|TMDX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ATEC|AORT (Artivion) - Earnings growth forecast for next year|Enovis Corp (ENOV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year IART|Expected earnings per share growth for next year Establishment Labs Inc ESTA|Earnings growth forecast for next year BBNX (Beta Bionics Inc)|Earnings growth forecast for next year iradimed.com IRMD|EMBC - Net earnings per share growth forecast for next year|TNDM: Net earnings per share growth forecast for next year|AXGN (Axogen Corp) - Expected earnings per share growth for next year|SI-BONE Medical - Expected earnings per share trend next year|OFIX (Orthofix Medical Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year bioventus.com BVS|Net earnings per share growth forecast for next year OrthoPediatrics Corp. (KIDS)|Treace Medical Concepts Inc (TMCI) - Net earnings per one share growth forecast for next year|Strata Critical Medical Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year Carlsmed Medical CARL|RxSight, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year ClearPoint Neuro, Inc. CLPT|Stereotaxis (STXS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year STIM (Neuronetics Inc.)|Net earnings per share growth forecast for next year Sight Sciences, Inc|Expected earnings per share growth for next year Orchestra BioMed Inc. (OBIO)|Earnings growth forecast for next year ANIK|NSPR - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Jin Medical ZJYL|VANI: Projected earnings per share growth rate for next year|XTNT: Expected earnings per share growth for next year|NeuroOne Medical Technologies Corp. - Projected earnings per share increase next year|MODD: Earnings growth forecast for next year|MYO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Envoy Medical|Projected earnings per share growth rate for next year VVOS (Vivos Therapeutics Inc.)|Expected earnings per share growth for next year NVNO (enVVeno)|Net earnings per share growth forecast for next year SINT (sintx.com)|Net earnings per share growth forecast for next year Tenon Medical, Inc. TNON|rewalk.com (LFWD) - Expected net earnings per share growth next year|AMIX: Expected earnings per share growth for next year|Expected earnings per share trend next year IVF (INVO Bioscience)|BBLG: Earnings growth forecast for next year|AXNX (Axonics, Inc) - Net earnings per share growth forecast for next year|BIOL (BIOLASE, Inc.) - Earnings growth forecast for next year|Dynatronics Corp. (DYNT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Paragon 28, Inc. (FNA)
